Abbott Laboratories vs. Amylyx Pharmaceuticals, Inc. Common Stock
ABT
Abbott Laboratories
$109.29 -1.06%
VS AMLXAmylyx Pharmaceuticals, Inc. Common Stock
$29.50 +6.81%
Amylyx Pharmaceuticals, Inc. Common Stock (AMLX) comes out ahead, leading on 2 of 3 compared factors.
Size & Scale
| ABT | AMLX | |
|---|---|---|
| Market Cap | $189.28 billion | $3.79 billion |
ABT leads on 1 of 1 size & scale factors.
Dividend
| ABT | AMLX | |
|---|---|---|
| Dividend Yield | 2.31% | 5.69% |
AMLX leads on 1 of 1 dividend factors.
Risk & Sentiment
| ABT | AMLX | |
|---|---|---|
| Short Interest | 0.57% | 0.00% |
AMLX leads on 1 of 1 risk & sentiment factors.
Dig deeper: ABT overview, ABT financials, AMLX overview, AMLX financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.